Q3 2024 Holdings
Filed 2024-11-14 | 196 holdings | $6.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tempus AI Inc(TEM) | CL A | 88023B103 | $29.2K | 516 | 0.0% |
| Labcorp Holdings Inc(LH) | COM SHS | 504922105 | $46.0K | 206 | 0.0% |
| Omniab Inc(OABI) | COM | 68218J103 | $48.5K | 11,456 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $61.5K | 41 | 0.0% |
| Qualcomm Inc(QCOM) | COM | 747525103 | $72.6K | 427 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $83.5K | 194 | 0.0% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $87.0K | 716 | 0.0% |
| Oracle Corp(ORCL) | COM | 68389X105 | $106.3K | 624 | 0.0% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $114.2K | 769 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $122.5K | 3,600 | 0.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $127.8K | 7,700 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $150.6K | 41,500 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $171.8K | 9,300 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $179.8K | 8,000 | 0.0% |
| Garmin LTD(GRMN) | SHS | H2906T109 | $184.8K | 1,050 | 0.0% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $199.8K | 16,499 | 0.0% |
| Baidu Inc(BIDUN) | SPON ADR REP A | 056752108 | $210.6K | 2,000 | 0.0% |
| Summit Therapeutics IncCall | CALL | 86627T908 | $219.0K | 10,000 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $221.8K | 4,400 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $222.2K | 4,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $228.1K | 7,200 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $233.4K | 1,100 | 0.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $264.8K | 10,400 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $265.7K | 13,600 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $296.0K | 3,200 | 0.0% |
| Nike Inc(NKE) | CL B | 654106103 | $309.4K | 3,500 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $322.8K | 8,200 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $334.0K | 4,000 | 0.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $367.4K | 39,500 | 0.0% |
| Merus N V | COM | N5749R100 | $399.7K | 8,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $433.7K | 31,000 | 0.0% |
| Viatris Inc(VTRS) | COM | 92556V106 | $456.1K | 39,283 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $457.3K | 15,700 | 0.0% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $469.0K | 24,015 | 0.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $510.6K | 2,634 | 0.0% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $517.7K | 25,900 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $549.3K | 19,046 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $555.6K | 12,346 | 0.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $577.7K | 10,941 | 0.0% |
| Amneal Pharmaceuticals Inc(AMRX) | COM STK CL A | 03168L105 | $635.8K | 76,414 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $822.5K | 15,700 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $869.9K | 4,779 | 0.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $870.7K | 15,109 | 0.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $934.9K | 5,625 | 0.0% |
| Alphabet Inc(GOOG) | CAP STK CL C | 02079K107 | $1.0M | 6,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.0M | 16,179 | 0.0% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $1.0M | 5,284 | 0.0% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $1.0M | 8,721 | 0.0% |
| Certara Inc(CERT) | COM | 15687V109 | $1.1M | 95,924 | 0.0% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $1.3M | 29,060 | 0.0% |